Advancements in genomic research have led to the development of polygenic risk scores (PRS) for breast cancer. These scores, calculated from the analysis of numerous genetic variants across an individual's genome, can predict a person's lifetime risk of developing breast cancer. PRS holds the promise for personalized screening and prevention strategies, enabling interventions at an earlier stage for those at highest risk.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.